International Journal of Science and Research (IJSR)

International Journal of Science and Research (IJSR)
Call for Papers | Fully Refereed | Open Access | Double Blind Peer Reviewed

ISSN: 2319-7064


Downloads: 23 | Views: 181 | Weekly Hits: ⮙3 | Monthly Hits: ⮙5

Review Papers | Pharmaceutical Science | India | Volume 13 Issue 3, March 2024 | Popularity: 6.7 / 10


     

Nanotechnology in Bladder Cancer

Sobana, William Arputha Sundar, Aarthi, Sharmila Begum


Abstract: Bladder cancer (BC) is the second most common cancer of the urinary tract in men and the fourth most common cancer in women, and its incidence rises with age. There are many conventional methods for diagnosis and treatment of BC. There are some current biomarkers and clinical tests for the diagnosis and treatment of BC. For example, radiotherapy combined with chemotherapy and surgical, but residual tumours cells mostly cause tumour recurrence. In addition, chemotherapy after transurethral resection causes high side effects, and lack of selectivity, and low sensitivity in sensing. Therefore, it is essential to improve new procedures for the diagnosis and treatment of BC. Nanotechnology has recently sparked an interest in a variety of areas, including medicine, chemistry, physics, and biology. Nanoparticles (NP) have been used in tumour therapies as appropriate tools for enhancing drug delivery efficacy and enabling therapeutic performance. It is noteworthy, nanomaterial could be reduced the limitation of conventional cancer diagnosis and treatments. Since, the major disadvantages of therapeutic drugs are their insolubility in an aqueous solvent, for instance, paclitaxel (PTX) is one of the important therapeutic agents utilized to treating BC, due to its ability to prevent cancer cell growth. However, its major problem is the poor solubility, which has confirmed to be a challenge when improving stable formulations for BC treatment. In our review we have discussed about the technology and diagnosis and treatment in bladder cancer.


Keywords: bladder cancer, diagnosis, treatment, nanotechnology, chemotherapy


Edition: Volume 13 Issue 3, March 2024


Pages: 649 - 655


DOI: https://www.doi.org/10.21275/SR24308151012



Make Sure to Disable the Pop-Up Blocker of Web Browser




Text copied to Clipboard!
Sobana, William Arputha Sundar, Aarthi, Sharmila Begum, "Nanotechnology in Bladder Cancer", International Journal of Science and Research (IJSR), Volume 13 Issue 3, March 2024, pp. 649-655, https://www.ijsr.net/getabstract.php?paperid=SR24308151012, DOI: https://www.doi.org/10.21275/SR24308151012



Similar Articles

Downloads: 172 | Weekly Hits: ⮙5 | Monthly Hits: ⮙5

Research Paper, Pharmaceutical Science, India, Volume 6 Issue 5, May 2017

Pages: 2214 - 2218

Drug Utilization Evaluation of Antiepileptic Drugs in a Tertiary Care Hospital

Nethaji Ramalingam, Anuroop Jose, Arun S, Arya Shihab, Devika S, Sudeep Balakrishnan, Babu Ganesan

Share this Article

Downloads: 126 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1

Informative Article, Pharmaceutical Science, India, Volume 8 Issue 12, December 2019

Pages: 1349 - 1355

Orphan Drugs

Priya Shaju

Share this Article

Downloads: 0

Research Paper, Pharmaceutical Science, India, Volume 11 Issue 4, April 2022

Pages: 634 - 638

Formulation and Evaluation of Controlled Release Matrix Tablets Containing Sotalol Hydrochloride

Nagendra R, Charan CS, K. Hanumanthachar Joshi

Share this Article

Downloads: 0

Review Papers, Pharmaceutical Science, India, Volume 11 Issue 5, May 2022

Pages: 1541 - 1547

Advancement in Edible Medicated Jelly

Mrynal Chamoli, Shaffi Khurana Tangri

Share this Article

Downloads: 0

Review Papers, Pharmaceutical Science, India, Volume 11 Issue 6, June 2022

Pages: 1099 - 1104

Phytopharmaceuticals Used as Immunomodulator: An Overview

Arvind Raghav, Lakshita Sharma

Share this Article
Top